|
|
Volumn 52, Issue 9, 1999, Pages 1920-1921
|
|
A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment [1] (multiple letters)
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SELEGILINE;
THIOACID;
ANTIOXIDANT;
MONOAMINE OXIDASE INHIBITOR;
THIOCTIC ACID;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DOPAMINE METABOLISM;
DOPAMINERGIC ACTIVITY;
DOPAMINERGIC SYSTEM;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
NEUROPROTECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
COMPARATIVE STUDY;
NOTE;
VIROLOGY;
ANTIOXIDANTS;
COGNITION DISORDERS;
DOUBLE-BLIND METHOD;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
SELEGILINE;
THIOCTIC ACID;
|
|
EID: 0033542308
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.52.9.1920 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|